Indian Journall Surg. -microRNAs New-Age Panacea in Cancer Therapeutics

Terapêutica cancro

Neelanjana Sarkar, Arun Kumar · 2020

MicroRNAs (miRNAs) are small (~ 18–25 nucleotides in length), endogenous, non-coding RNAs, which…

Apresentação Dr. William Makis sobre NEO e medicamentos reposicionados

Terapêutica cancro

William Makis · 2024

Ensaio Sunshine – Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up

Terapêutica cancro

Mathijs C. Bodde · Maaike P. J. Hermans · J. Wouter Jukema · Martin J. Schalij · Willem M. Lijfering · Frits R. Rosendaal · Fred P. H. T. M. Romijn · L. Renee Ruhaak · Arnoud van der Laarse · Christa M. Cobbaert · 2019

The current way to assess the risk of cardiovascular disease (CVD) is to…

Anticancer research – Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients

Terapêutica cancro

Nicolas Hulscher, Kelly Victory, James A. Thorp, Drew Pinsky, Alejandro Diaz-Villalobos, Peter Gillooly, Foster Coulson, Melissa Annazone, Chloe Radesi, Jessica Brooks, Peter A. McCullough, Harvey Risch · 2026

Results from a Prospective Observational Cohort. Drug repurposing offers a pathway to identify…

Parasitic Society – Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update

Terapêutica cancro

Jong-Yil Chai, Bong-Kwang Jung, Sung-Jong Hong · 2021

The use of albendazole and mebendazole, i.e., benzimidazole broad-spectrum anthelmintics, in treatment of…

PMC- Integrated analysis reveals FOXA1 and Ku70-Ku80 as targets of ivermectin in prostate cancer

Terapêutica cancro

Shidong Lv, Zeyu Wu, Mayao Luo, Yifan Zhang, Jianqiang Zhang, Laura E. Pascal, Zhou Wang, Qiang Wei · 2022

Ivermectin is a widely used antiparasitic drug and shows promising anticancer activity in…

Ivermectin – Benzimidazole Prescribing Following Celebrity Endorsement

Terapêutica cancro

Michelle S. Rockwell; Katherine L. Kahn; A. Mark Fendrick; Sitaram Vangala; JohnN. Mafi · 2026

In early January 2025, high-profilemedia figures promoted a combination ivermectin-fenbendazole regimen as anoff-label…

MCP – Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging

Terapêutica cancro

Fábio Fernando Alves da Silva, Sofia Nascimento dos Santos, Lucas de Freitas Pedrosa, Vinicius Gonçalves Rodrigues, Jonathas Xavier Pereira, Jhonatas Pedrosa Marim Pereira, Dino Seigo Gushiken Junior, Thiécla Katiane Osvaldt Rosales, Luís Alberto Pereira Dias, Patrick Jack Spencer, João Paulo Fabi, Emerson Soares Bernardes · 2026

ABSTRACT: This study employed molecular imaging to evaluate MCP (PectaSol-C, modified citrus pectin,…

MCP-SAGE Journals – Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study

Terapêutica cancro

Marc Azémar, Bernd Hildenbrand, Brigitte Haering, Manfred E. Heim, Clemens Unger · 2007

We conducted a pilot trial to assess the tolerability, clinical benefit and antitumoral…

MCP – Anti-Cancer Pectins and Their Role in Colorectal Cancer Treatment

Terapêutica cancro

Andrea Cedillo Ornelas, Sam Ferguson, Maya DePlaza, Tkai Adekunle, Riyaz Basha · 2022

A class of plant polysaccharides, pectin is known to display several medicinal properties…

MCP – Pectin: A Bioactive Food Polysaccharide with Cancer Preventive Potential

Terapêutica cancro

Talha Bin Emran, Fahadul Islam, Saikat Mitra, Shyamjit Paul, Nikhil Nath, Zidan Khan, Rajib Das, Deepak Chandran, Rohit Sharma, Clara Mariana Gonçalves Lima, Ahmed Abdullah Al Awadh, Ibrahim Abdullah Almazni, Abdulaziz Hassan Alhasaniah, Raquel P. F. Guiné · 2022

Pectin is an acidic heteropolysaccharide found in the cell walls and the primary…

MCP – Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study

Terapêutica cancro

Daniel Keizman, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, David Margel, Ido Wolf, Ravit Geva, Hadas Dresler, Keren Rouvinov, Noa Rapoport 3 and Isaac Eliaz · 2021

Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive.…